Affiliation:
1. University of Oklahoma College of Medicine; Oklahoma City OK USA
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference28 articles.
1. Blood pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomized, double-blind, placebo-controlled, active comparator study;Ruilope;Lancet,2010
2. Combined, neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis;Solomon;Eur J Heart Fail,2016
3. LCZ696, angiotensin AT1 receptor blocker/neprisylin inhibitor for the treatment of heart failure and hypertension;Chrysant;Drugs of the Future,2011
4. Clinical experience with angiotensin receptor blockers with particular reference to valsartan;Chrysant;J Clin Hypertens (Greenwich),2004
5. Natriuretic peptides and therapeutic implications;Lee;Heart Fail Rev,2007
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献